Skip to main content
. 2023 Jul 13;6(3):447–467. doi: 10.20517/cdr.2023.21

Table 1.

TCTP expression and clinical outcomes

Cancer Expression level Histological and prognostic features Refs
Breast High Poor differentiation
Short survival
[18]
[19]
Epithelial ovarian cancer High Poor differentiation
Short survival
Lymph node metastasis
[20]
Cervical cancer High Poor differentiation
Lymph node metastasis
[21]
Gallbladder cancer High Poor differentiation
Metastasis
Short survival
[22]
Pancreatic ductal adenocarcinoma High Lymph node metastasis
Poor differentiation
[23]
Glioma High Poor differentiation
Short survival
[24]
[25]
Colorectal cancer High Poor differentiation
Metastatic
Short survival
[26]
[27]
Prostate High Poor differentiation
Metastasis
Short survival
[28]
[29]
Lung adenocarcinoma High Poor differentiation
Short survival
[30]
NSCLC High Tumor size
Short survival
[31]
Cholangiocarcinoma High Short survival [32]
Neurofibromatosis type 1 High Malignant phenotype [33]
Neuroblastoma High Poor differentiation
Short survival
[34]

TCTP: Translationally controlled tumor protein.